Upadacitinib for Refractory Alopecia Areata Unresponsive to Prior Systemic Therapies: A Retrospective Study

Published: 21 November 2024| Version 1 | DOI: 10.17632/zs5fkwwg6d.1
Contributor:
Wang Qin

Description

Supplemental table detailing baseline SALT scores, changes in SALT scores, and serum IgE levels for each patient with refractory alopecia areata following treatment with Upadacitinib.

Files

Institutions

  • Huashan Hospital Fudan University

Categories

Alopecia Areata

Funders

Licence